These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34672206)

  • 1. The latest developments in the area of therapeutic delivery excluding some diseases, such as COVID-19 and the big three (HIV/AID, malaria and tuberculosis).
    Reis CP
    Ther Deliv; 2021 Dec; 12(12):799-805. PubMed ID: 34672206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.
    Velavan TP; Meyer CG; Esen M; Kremsner PG; Ntoumi F;
    Int J Infect Dis; 2021 May; 106():29-32. PubMed ID: 33781904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An industry update: the latest news in therapeutic delivery.
    Harris E
    Ther Deliv; 2017 Nov; 8(11):939-946. PubMed ID: 29061099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry Update: the latest developments in therapeutic delivery.
    Steinbach OC
    Ther Deliv; 2013 May; 4(5):531-5. PubMed ID: 23647270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.
    Villanustre F; Chala A; Dev R; Xu L; LexisNexis JS; Furht B; Khoshgoftaar T
    J Big Data; 2021; 8(1):33. PubMed ID: 33614394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Burdens of the COVID-19, Malaria, Tuberculosis, and HIV/AIDS Epidemics in Sub-Saharan Africa.
    Bell D; Schultz Hansen K
    Am J Trop Med Hyg; 2021 Oct; 105(6):1510-1515. PubMed ID: 34634773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An industry update: the latest developments in therapeutic delivery.
    Simpson I
    Ther Deliv; 2018 Jan; 9(1):9-15. PubMed ID: 29216806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US-FDA Approved Drugs in 2020 and 2021: A Review.
    Passi I; Salwan S; Kumar B
    Mini Rev Med Chem; 2023; 23(12):1273-1297. PubMed ID: 36503454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry Update: the latest developments in therapeutic delivery.
    Steinbach OC
    Ther Deliv; 2014 May; 5(5):505-9. PubMed ID: 24998270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing health risks associated with the COVID-19 pandemic and early response: A scoping review.
    Baral S; Rao A; Rwema JOT; Lyons C; Cevik M; Kågesten AE; Diouf D; Sohn AH; Phaswana-Mafuya RN; Kamarulzaman A; Millett G; Marcus JL; Mishra S
    PLoS One; 2022; 17(8):e0273389. PubMed ID: 36037216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Pandemic-to-Endemic Transition in Indonesia: What Does the Future Hold?
    Sinto R
    Acta Med Indones; 2022 Apr; 54(2):159-160. PubMed ID: 35818655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management.
    Terpos E; Branagan AR; García-Sanz R; Trotman J; Greenberger LM; Stephens DM; Morel P; Kimby E; Frustaci AM; Hatjiharissi E; San-Miguel J; Dimopoulos MA; Treon SP; Leblond V
    Semin Hematol; 2023 Mar; 60(2):107-112. PubMed ID: 37099029
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.